In conclusion, serum Asprosin level increased and Nrg-4 level decreased in patients with CHD, which is closely related to glucose and lipid metabolism disorder and insulin resistance, and has certain significance for the prediction and diagnosis of T2DM with CHD. The gene discussed is FBN1; the disease is type 2 diabetes mellitus.